Setting

Global Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Region: Trend Forecast and Growth Opportunity

Published: 28 Feb 2023 | Report Code: 10248970 | Pages: 168

Global genital herpes treatment market will reach $5,051.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports. Highlighted with 84 tables and 80 figures, this 168-page report “Global Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Region. Based on Virus Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • HSV-1 • HSV-2 Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Acyclovir • Valacyclovir • Famciclovir • Other Drugs By Route of Administration, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Oral • Topical • Injection By Patient Gender, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Female • Male By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Retail Pharmacies • Hospital Pharmacies • Online Pharmacies • Drug Stores Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE?Saudi Arabia? South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and split of each national market by Virus Type, Drug Type and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott ADLEY FORMULATIONS Aurobindo Pharma Ltd. Avet Pharmaceuticals Inc. Bausch Health Companies Centurion Remedies Cipla Ltd. Eli Lilly & Company Finecure Pharmaceuticals GlaxoSmithKline Plc Glenmark Pharmaceuticals Macleods Pharmaceuticals Medico Remedies Merck & Co., Inc. Novartis AG Pfizer Reddy's Laboratories Sanofi SA Teva Pharmaceutical Industries Ltd. Torrent Pharma Viatris Inc. Zeelab Pharmacy Zydus Pharmaceuticals, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction	9
1.1 Industry Definition and Research Scope	9
1.1.1 Industry Definition	9
1.1.2 Research Scope	10
1.2 Research Methodology	13
1.2.1 Overview of Market Research Methodology	13
1.2.2 Market Assumption	14
1.2.3 Secondary Data	14
1.2.4 Primary Data	14
1.2.5 Data Filtration and Model Design	15
1.2.6 Market Size/Share Estimation	16
1.2.7 Research Limitations	17
1.3 Executive Summary	18
2 Market Overview and Dynamics	21
2.1 Market Size and Forecast	21
2.1.1 Impact of COVID-19 on World Economy	22
2.1.2 Impact of COVID-19 on the Market	25
2.2 Major Growth Drivers	27
2.3 Market Restraints and Challenges	31
2.4 Emerging Opportunities and Market Trends	34
2.5 Porter’s Fiver Forces Analysis	38
3 Segmentation of Global Market by Virus Type	42
3.1 Market Overview by Virus Type	42
3.2 HSV-1	44
3.3 HSV-2	45
4 Segmentation of Global Market by Drug Type	46
4.1 Market Overview by Drug Type	46
4.2 Acyclovir	48
4.3 Valacyclovir	49
4.4 Famciclovir	50
4.5 Other Drugs	51
5 Segmentation of Global Market by Route of Administration	53
5.1 Market Overview by Route of Administration	53
5.2 Oral	55
5.3 Topical	56
5.4 Injection	57
6 Segmentation of Global Market by Patient Gender	58
6.1 Market Overview by Patient Gender	58
6.2 Female	60
6.3 Male	61
7 Segmentation of Global Market by Distribution Channel	62
7.1 Market Overview by Distribution Channel	62
7.2 Retail Pharmacies	64
7.3 Hospital Pharmacies	65
7.4 Online Pharmacies	66
7.5 Drug Stores	67
8 Segmentation of Global Market by Region	68
8.1 Geographic Market Overview 2022-2032	68
8.2 North America Market 2022-2032 by Country	72
8.2.1 Overview of North America Market	72
8.2.2 U.S.	76
8.2.3 Canada	81
8.2.4 Mexico	83
8.3 European Market 2022-2032 by Country	85
8.3.1 Overview of European Market	85
8.3.2 Germany	89
8.3.3 U.K.	91
8.3.4 France	93
8.3.5 Spain	95
8.3.6 Italy	97
8.3.7 Netherlands	99
8.3.8 Rest of European Market	101
8.4 Asia-Pacific Market 2022-2032 by Country	103
8.4.1 Overview of Asia-Pacific Market	103
8.4.2 Japan	107
8.4.3 China	110
8.4.4 Australia	112
8.4.5 India	114
8.4.6 South Korea	116
8.4.7 Rest of APAC Region	118
8.5 South America Market 2022-2032 by Country	120
8.5.1 Argentina	123
8.5.2 Brazil	125
8.5.3 Chile	127
8.5.4 Rest of South America Market	129
8.6 MEA Market 2022-2032 by Country	130
8.6.1 UAE	133
8.6.2 Saudi Arabia	135
8.6.3 South Africa	137
8.6.4 Other National Markets	139
9 Competitive Landscape	140
9.1 Overview of Key Vendors	140
9.2 New Product Launch, Partnership, Investment, and M&A	143
9.3 Company Profiles	144
Abbott	144
ADLEY FORMULATIONS	146
Aurobindo Pharma Ltd.	147
Avet Pharmaceuticals Inc.	148
Bausch Health Companies	149
Centurion Remedies	150
Cipla Ltd.	151
Eli Lilly & Company	152
Finecure Pharmaceuticals	153
GlaxoSmithKline Plc	154
Glenmark Pharmaceuticals	155
Macleods Pharmaceuticals	156
Medico Remedies	157
Merck & Co., Inc.	158
Novartis AG	159
Pfizer	160
Reddy's Laboratories	161
Sanofi SA	162
Teva Pharmaceutical Industries Ltd.	163
Torrent Pharma	164
Viatris Inc.	165
Zeelab Pharmacy	166
Zydus Pharmaceuticals, Inc.	167
RELATED REPORTS	168
List of Tables:

Table 1.  Snapshot of Global Genital Herpes Treatment Market in Balanced Perspective, 2022-2032	19
Table 2. World Economic Outlook, 2021-2031	23
Table 3. World Economic Outlook, 2021-2023	24
Table 4. World Health Spending by Region, $ bn, 2013-2020	30
Table 5.  Main Product Trends and Market Opportunities in Global Genital Herpes Treatment Market	34
Table 6. Global Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	42
Table 7. Global Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	46
Table 8. Side Effects of Genital Herpes Medications	46
Table 9. Vaccine Pipelines for Herpes	52
Table 10. Global Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn	53
Table 11. Global Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn	58
Table 12. Global Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	62
Table 13. Global Genital Herpes Treatment Market by Region, 2022-2032, $ mn	69
Table 14.  Leading National Genital Herpes Treatment Market, 2022 and 2032, $ mn	71
Table 15. North America Genital Herpes Treatment Market by Country, 2022-2032, $ mn	74
Table 16. U.S. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	80
Table 17. U.S. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	80
Table 18. U.S. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	80
Table 19. Canada Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	82
Table 20. Canada Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	82
Table 21. Canada Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	82
Table 22. Mexico Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	84
Table 23. Mexico Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	84
Table 24. Mexico Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	84
Table 25. Europe Genital Herpes Treatment Market by Country, 2022-2032, $ mn	88
Table 26. Germany Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	90
Table 27. Germany Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	90
Table 28. Germany Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	90
Table 29. U.K. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	92
Table 30. U.K. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	92
Table 31. U.K. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	92
Table 32. France Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	94
Table 33. France Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	94
Table 34. France Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	94
Table 35. Spain Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	96
Table 36. Spain Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	96
Table 37. Spain Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	96
Table 38. Italy Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	98
Table 39. Italy Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	98
Table 40. Italy Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	98
Table 41. Netherlands Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	100
Table 42. Netherlands Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	100
Table 43. Netherlands Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	100
Table 44. Genital Herpes Treatment Market in Rest of Europe by Country, 2022-2032, $ mn	102
Table 45. APAC Genital Herpes Treatment Market by Country, 2022-2032, $ mn	105
Table 46. Japan Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	109
Table 47. Japan Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	109
Table 48. Japan Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	109
Table 49. China Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	111
Table 50. China Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	111
Table 51. China Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	111
Table 52. Australia Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	113
Table 53. Australia Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	113
Table 54. Australia Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	113
Table 55. India Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	115
Table 56. India Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	115
Table 57. India Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	115
Table 58. South Korea Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	117
Table 59. South Korea Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	117
Table 60. South Korea Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	117
Table 61. Genital Herpes Treatment Market in Rest of APAC by Country/Region, 2022-2032, $ mn	119
Table 62. South America Genital Herpes Treatment Market by Country, 2022-2032, $ mn	122
Table 63. Argentina Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	124
Table 64. Argentina Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	124
Table 65. Argentina Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	124
Table 66. Brazil Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	126
Table 67. Brazil Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	126
Table 68. Brazil Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	126
Table 69. Chile Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	128
Table 70. Chile Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	128
Table 71. Chile Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	128
Table 72. MEA Genital Herpes Treatment Market by Country, 2022-2032, $ mn	132
Table 73. UAE Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	134
Table 74. UAE Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	134
Table 75. UAE Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	134
Table 76. Saudi Arabia Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	136
Table 77. Saudi Arabia Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	136
Table 78. Saudi Arabia Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	136
Table 79. South Africa Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	138
Table 80. South Africa Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	138
Table 81. South Africa Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	138
Table 82. Abbott: Company Snapshot	144
Table 83. Abbott: Business Segmentation	145
Table 84. Abbott: Product Portfolio	145

List of Figures:

Figure 1. Research Method Flow Chart	13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032	18
Figure 4. Global Genital Herpes Treatment Market, 2022-2032, $ mn	21
Figure 5. Impact of COVID-19 on Business	25
Figure 6. Primary Drivers and Impact Factors of Global Genital Herpes Treatment Market	27
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million	30
Figure 8. Primary Restraints and Impact Factors of Global Genital Herpes Treatment Market	31
Figure 9. Investment Opportunity Analysis	35
Figure 10. Porter’s Fiver Forces Analysis of Global Genital Herpes Treatment Market	38
Figure 11. Breakdown of Global Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue	43
Figure 12. Global Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%)	43
Figure 13. Global Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn	44
Figure 14. Global Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn	45
Figure 15. Breakdown of Global Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue	47
Figure 16. Global Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)	47
Figure 17. Global Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn	48
Figure 18. Global Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn	49
Figure 19. Global Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn	50
Figure 20. Global Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn	51
Figure 21. Breakdown of Global Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue	54
Figure 22. Global Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)	54
Figure 23. Global Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn	55
Figure 24. Global Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn	56
Figure 25. Global Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn	57
Figure 26. Breakdown of Global Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue	59
Figure 27. Global Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%)	59
Figure 28. Global Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn	60
Figure 29. Global Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn	61
Figure 30. Breakdown of Global Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue	63
Figure 31. Global Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)	63
Figure 32. Global Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn	64
Figure 33. Global Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn	65
Figure 34. Global Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn	66
Figure 35. Global Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn	67
Figure 36.  Global Market Snapshot by Region	68
Figure 37.  Geographic Spread of Worldwide Genital Herpes Treatment Market, 2022-2032, % of Sales Revenue	69
Figure 38. Global Addressable Market Cap in 2023-2032 by Region, Value ($ mn) and Share (%)	70
Figure 39.  North American Genital Herpes Treatment Market, 2022-2032, $ mn	73
Figure 40. Breakdown of North America Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue	74
Figure 41. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)	75
Figure 42. Percentage of LGBT in Total Population in U.S., 2012-2021	77
Figure 43. Estimated Number of New (Incident) and Existing (Prevalent) Sexually Transmitted Infections in U.S. in 2018	78
Figure 44. Healthcare Cost by STI Type in U.S. in 2018	79
Figure 45. U.S. Genital Herpes Treatment Market, 2022-2032, $ mn	79
Figure 46. Canada Genital Herpes Treatment Market, 2022-2032, $ mn	81
Figure 47.  Genital Herpes Treatment Market in Mexico, 2022-2032, $ mn	83
Figure 48.  European Genital Herpes Treatment Market, 2022-2032, $ mn	86
Figure 49. Breakdown of European Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue	87
Figure 50. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)	88
Figure 51.  Genital Herpes Treatment Market in Germany, 2022-2032, $ mn	89
Figure 52.  Genital Herpes Treatment Market in U.K., 2022-2032, $ mn	91
Figure 53.  Genital Herpes Treatment Market in France, 2022-2032, $ mn	93
Figure 54.  Genital Herpes Treatment Market in Spain, 2022-2032, $ mn	95
Figure 55.  Genital Herpes Treatment Market in Italy, 2022-2032, $ mn	97
Figure 56.  Genital Herpes Treatment Market in Netherlands, 2022-2032, $ mn	99
Figure 57.  Genital Herpes Treatment Market in Rest of Europe, 2022-2032, $ mn	101
Figure 58. Asia-Pacific Genital Herpes Treatment Market, 2022-2032, $ mn	104
Figure 59. Breakdown of APAC Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue	104
Figure 60. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)	106
Figure 61.  Genital Herpes Treatment Market in Japan, 2022-2032, $ mn	108
Figure 62.  Genital Herpes Treatment Market in China, 2022-2032, $ mn	110
Figure 63.  Genital Herpes Treatment Market in Australia, 2022-2032, $ mn	112
Figure 64.  Genital Herpes Treatment Market in India, 2022-2032, $ mn	114
Figure 65.  Genital Herpes Treatment Market in South Korea, 2022-2032, $ mn	116
Figure 66.  Genital Herpes Treatment Market in Rest of APAC, 2022-2032, $ mn	118
Figure 67. South America Genital Herpes Treatment Market, 2022-2032, $ mn	121
Figure 68. Breakdown of South America Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue	121
Figure 69. Contribution to South America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)	122
Figure 70.  Genital Herpes Treatment Market in Argentina, 2022-2032, $ mn	123
Figure 71.  Genital Herpes Treatment Market in Brazil, 2022-2032, $ mn	125
Figure 72.  Genital Herpes Treatment Market in Chile, 2022-2032, $ mn	127
Figure 73.  Genital Herpes Treatment Market in Rest of South America, 2022-2032, $ mn	129
Figure 74. Genital Herpes Treatment Market in Middle East and Africa (MEA), 2022-2032, $ mn	131
Figure 75. Breakdown of MEA Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue	131
Figure 76. Contribution to MEA 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)	132
Figure 77.  Genital Herpes Treatment Market in UAE, 2022-2032, $ mn	133
Figure 78.  Genital Herpes Treatment Market in Saudi Arabia, 2022-2032, $ mn	135
Figure 79.  Genital Herpes Treatment Market in South Africa, 2022-2032, $ mn	137
Figure 80. Growth Stage of Global Genital Herpes Treatment Industry over the Forecast Period	140

Selected Key Players: 
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)